Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II.
about
Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Morbidity and Outcomes Followi ...... Surgery in the Era of MSLT-II.
@en
Morbidity and Outcomes Followi ...... Surgery in the Era of MSLT-II.
@nl
type
label
Morbidity and Outcomes Followi ...... Surgery in the Era of MSLT-II.
@en
Morbidity and Outcomes Followi ...... Surgery in the Era of MSLT-II.
@nl
prefLabel
Morbidity and Outcomes Followi ...... Surgery in the Era of MSLT-II.
@en
Morbidity and Outcomes Followi ...... Surgery in the Era of MSLT-II.
@nl
P2093
P2860
P1476
Morbidity and Outcomes Followi ...... Surgery in the Era of MSLT-II.
@en
P2093
Alexandra M Seamens
Clara R Farley
Keith A Delman
Lauren M Postlewait
Maria C Russell
Michael C Lowe
Monica Rizzo
P2860
P2888
P304
P356
10.1245/S10434-017-6242-3
P577
2017-11-20T00:00:00Z
P6179
1092813126